Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Related to
Merck Sharp & Dohme Sweden AB
Merck is a biopharmaceutical company that develops and provides innovative medicines and vaccines to save and improve lives globally.
Sector
Subsector
Keywords
Location
total rounds
total raised
count Of Investments
count Of Exists
Industry
Sector :
Subsector :
Keywords :
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
Similar Companies1000
Concortis BioSystems
Concortis is a biotechnology company that develops next-generation biotherapeutics.
Sector
Subsector
Keywords
Location
Sapreme Technologies
Sapreme Technologies improves macromolecule therapeutic delivery and efficacy.
Sector
Subsector
Location
total rounds
total raised
Cisterna Biologics
Cisterna Biologics uses proprietary technologies to purify mRNA from yeast for developing mRNA-based therapeutics.
Sector
Subsector
Keywords
total rounds
Allozyne
Allozyne develops and commercializes technologies to improve protein-based therapeutics for multiple sclerosis and other diseases.
Sector
Subsector
Keywords
Location
total rounds
total raised
M&A Details1
Transaction name
Acquired by
Merck Sharp & Dohme Sweden AB
announced date
price
Financials
Funding Rounds1
Number of Funding Rounds
Money Raised
Their latest funding was raised on 09.10.2005. Their latest investor Boston Millennia Partners. Their latest round Series C
Co-Investors
Investors9
Number of lead investors
Number of investors
Boston Millennia Partners
Boston Millennia Partners is a growth capital investing firm focused on healthcare and business services industries.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Fletcher Spaght, Inc.
Fletcher Spaght helps healthcare and tech companies grow revenue and potential.
Sector
Subsector
Location
count Of Investments
count Of Exists
Village Ventures
Village Ventures is a venture capital firm that invests in early stage digital media and financial services companies.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
People
Founders2
Charles Hutchinson
Charles Hutchinson, PhD, Chairman of the Board, was Dean of the Thayer School of Engineering, Dartmouth College from 1984 until 1994 and again from 1997 to 1998. While Dean of Thayer he established the Master of Engineering Management program and in 2007 helped establish the PhD Innovation Program. The latter modifies and supplements the doctoral engineering curriculum with entrepreneurial studies, the goal being to equip engineering students to start companies. Dr. Hutchinson’s interest in entrepreneurship is longstanding: In 1997, he founded M2S, a company specializing in medical data and image management services for clinical trials. In 2000, he co-founded the technology start-up GlycoFi Inc., which creates bio-therapeutics based on glycan optimization technology and was acquired by Merck in 2006 for $400 million. Finally, in 2007 he was among the co-founders of SustainX.
current job
organization founded
Charles Hutchinson
Tillman Gerngross
Tillman Gerngross Co-Founded Adimab, LLC. in 2007 and serves as its Chief Executive Officer. Tillman Gergross is Founder of Arsanis Inc. and serves as its Chairman of the Board. Tillman Gergross Co-Founded Kreogene. He is a Co-Founder and Chairman of Alector LLC and Arsanis, Inc. He Co-Founded Avitide, Inc and serves as its Chairman of the Board.
current job
Tillman Gerngross
Employee Profiles8
Richard Fisher
Senior VP, Research and Product Development
James Posada
Senior Vice President of Business and Market Development